VVY — Vivoryon Therapeutics NV Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Vivoryon Therapeutics NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	26.3	17.7	30.3	28.6	9.39
Net Total Accounts Receivable
Net Total Receivables	0.129	0.293	0.256	0.512	0.312
Prepaid Expenses
Total Other Current Assets
Total Current Assets	28.8	20.2	30.7	29.8	10.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.39	0.285	0.176	0.076	0.124
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Total Assets	29.8	24.5	31.4	30.8	11.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.32	5.05	3.27	3.18	1.4
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	3.53	7.96	4.87	4.55	3.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	26.2	16.6	26.5	26.3	7.88
Total Liabilities & Shareholders' Equity	29.8	24.5	31.4	30.8	11.3
Total Common Shares Outstanding